FDA launches pilot to collect real-time clinical trial data

The FDA announced a new pilot program that will gather clinical trial information as it is generated, allowing reviewers to see data in real time.

The agency says this approach could speed up evaluation and improve oversight by providing continuous insight rather than waiting for final study reports.

AstraZeneca and Amgen have been selected as the first companies to participate in the pilot, testing the system on their ongoing trials.